Herceptin Trastuzumab Trademark Details

Herceptin Trastuzumab was registered on Tuesday, July 29, 2008 and is currently owned by Genentech, Inc. under the registration number 3478203 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 9 years ago on Monday, July 28, 2014, according to the United State Patent & Trademark Office
Word Mark Herceptin Trastuzumab
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Genentech, Inc. of South San Francisco, CA

View all trademarks for Genentech, Inc.
Other Trademarks for Genentech, Inc.
Serial Number 78894502
Registration Number 3478203
Status Date Monday, July 28, 2014
Filing Date Monday, July 28, 2014
Registration Date Tuesday, July 29, 2008
Attorney Ronald E. Shapiro

Correspondent

Ronald E. Shapiro
Shapiro and Silverstein PLLC
11350 Random Hills Road, Suite 740
Fairfax VA 22030

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Goods & Services Printed educational and informational publications, namely, reports on conference seminars and discussions, summary reports on conference seminars and discussions, newsletters, bulletins, brochures, training materials, and leaflets; all of the foregoing related to the fields of medicine and medicinal treatment

Classifications

International Class Codes
016 — Class 16 includes mainly paper, goods made from that material and office requisites.
U.S. Class Codes 002, 005, 022, 023, 029, 037, 038, 050
Status 6 — Active
Status Date Friday, June 2, 2006
First Use Anywhere Wednesday, November 1, 2006
First Use In Commerce Wednesday, November 1, 2006
Primary Code 016

You must be signed in to print.

Once signed in, look for the PDF button.